Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.020
0.00 (0.00%)
At close: Jul 27, 2026
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $49.38 million as of July 28, 2026. Its market cap has decreased by -33.30% in one year.
Market Cap
49.38M
Enterprise Value
50.22M
Revenue
4.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.02
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 49.38M, an increase of 148.70%. That is a compound annual growth rate of 10.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 49.38M | -47.98% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 99.00M |
| NDT Pharmaceuticals | 85.98M |
| BioStem Technologies | 71.08M |
| Vicapsys Life Sciences | 47.26M |
| Cell Source | 44.16M |
| Arch Biopartners | 41.09M |
| ProText Mobility | 36.92M |
| Sangamo Therapeutics | 26.93M |